TITLE:
Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients

CONDITION:
Congestive Heart Failure

INTERVENTION:
Tolvaptan

SUMMARY:

      Patients with congestive heart failure will be assessed for safety and clinical effects of
      Tolvaptan 30 mg every day versus 15 mg twice a day over a period of 7 days.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        History of CHF
      
